Skip to content
SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%
Market News

Moderna Shares Rocket 110% Pre-Market As Cancer Drug Trial Success

Business - Latest - Google News · August 19, 2026

Moderna Shares Rocket 110% Pre-Market As Cancer Drug Trial Success  NDTV ProfitModerna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock is soaring.  MarketWatchModerna Shares Skyrocket 125% Toward Best Day Ever—Here’s Why  ForbesPromising Results for mRNA Cancer Vaccine from Moderna and Merck  Time MagazineBrookline reiterates Moderna stock rating on positive melanoma data By Investing.com  Investing.com India

View original source →

More News

Anthropic To Woo Investors With $30-Trillion Market Opportunity Ahead Of Mega IPO
Rs 6,400-crore IPO rush: 7 companies set to tap primary market next week
Berkshire’s profit doubles as equity holdings surge; buys back $4.5 bln shares
2026 Maruti Baleno Facelift Launch Likely In Early September